Muscles don’t grow by filling up with water or sugar—they grow by adding more of the actual contractile parts that make them strong.
Scientific Claim
Sarcoplasmic hypertrophy—defined as disproportionate expansion of non-contractile muscle components like glycogen or fluid—is not a meaningful or persistent contributor to long-term muscle growth in humans, as most evidence indicates that muscle fiber enlargement is primarily due to proportional myofibrillar protein accretion.
Original Statement
“Evidence for sarcoplasmic hypertrophy as a distinct, functional contributor to muscle growth is weak; myofibrillar protein accretion remains the dominant adaptation... Jorgenson and colleagues... discovered that the radial growth of muscle fibers is largely mediated by myofibrillogenesis.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The review uses definitive language ('remains the dominant adaptation') but synthesizes studies with conflicting results. As a narrative review, it cannot definitively rule out sarcoplasmic hypertrophy; probability language is required.
More Accurate Statement
“Sarcoplasmic hypertrophy—defined as disproportionate expansion of non-contractile muscle components like glycogen or fluid—is unlikely to be a meaningful or persistent contributor to long-term muscle growth in humans, as most evidence indicates that muscle fiber enlargement is primarily due to proportional myofibrillar protein accretion.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aIn EvidenceThe relative contribution of myofibrillar vs. sarcoplasmic protein accretion to muscle hypertrophy across all human studies using protein synthesis tracers or proteomics.
The relative contribution of myofibrillar vs. sarcoplasmic protein accretion to muscle hypertrophy across all human studies using protein synthesis tracers or proteomics.
What This Would Prove
The relative contribution of myofibrillar vs. sarcoplasmic protein accretion to muscle hypertrophy across all human studies using protein synthesis tracers or proteomics.
Ideal Study Design
A meta-analysis of all human RCTs using deuterium oxide or stable isotope tracers to measure myofibrillar and sarcoplasmic protein synthesis rates over 4–12 weeks of resistance training, including at least 10 studies with >30 participants each.
Limitation: Cannot quantify structural changes in sarcoplasmic volume without imaging or biopsy.
Randomized Controlled TrialLevel 1bIn EvidenceThat high-volume training produces greater sarcoplasmic expansion than high-load training when myofibrillar synthesis is matched.
That high-volume training produces greater sarcoplasmic expansion than high-load training when myofibrillar synthesis is matched.
What This Would Prove
That high-volume training produces greater sarcoplasmic expansion than high-load training when myofibrillar synthesis is matched.
Ideal Study Design
A within-subject RCT with 20 trained men, training one leg with high-volume (32 sets/week) and the other with high-load (12 sets/week) for 8 weeks, measuring sarcoplasmic protein content via proteomics and fluid via MRI, while matching myofibrillar MPS via D2O tracer.
Limitation: Does not prove long-term persistence of sarcoplasmic changes.
Prospective Cohort StudyLevel 2bWhether bodybuilders with decades of high-volume training show persistent sarcoplasmic expansion compared to powerlifters.
Whether bodybuilders with decades of high-volume training show persistent sarcoplasmic expansion compared to powerlifters.
What This Would Prove
Whether bodybuilders with decades of high-volume training show persistent sarcoplasmic expansion compared to powerlifters.
Ideal Study Design
A 5-year prospective cohort of 50 bodybuilders and 50 powerlifters, with annual muscle biopsies measuring myofibrillar density, glycogen content, and mitochondrial volume, controlling for training volume and nutrition.
Limitation: Cannot control for genetic or supplement use differences over time.
Evidence from Studies
Supporting (1)
Load-induced human skeletal muscle hypertrophy: Mechanisms, myths, and misconceptions.
This study says that muscles grow bigger mainly because the actual working parts inside them (the contractile proteins) get stronger and more numerous—not because they just fill up with water or sugar. So the claim that non-working stuff doesn’t really make muscles grow long-term is backed up.